Hematology/Oncology

Top Story

VIDEO: Intralesional agent, immunotherapy combination may increase response in metastatic melanoma

March 27, 2017

NEW YORK — Robert H.I. Andtbacka, MD, CM, FACS, FRCSC, surgical oncologist at Huntsman Cancer Institute, and a HemOnc Today Editorial Board member, discussed the potential role of injectable immunotherapies and how they could change the tumor microenvironment in advanced melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.

FDA approvals

FDA approves Zejula for maintenance treatment of gynecologic cancers

March 27, 2017
The FDA today approved niraparib for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers who achieved…
In the Journals Plus

Close proximity to oil, gas development areas may increase risk for pediatric ALL

March 27, 2017
Young people living in Colorado diagnosed with acute lymphocytic leukemia were more likely to live in areas with a high-density of oil and gas development, according to…
In the Journals Plus

Imatinib confers long-term survival in patients with gastrointestinal stromal tumors

March 27, 2017
Imatinib treatment conferred a “durable, long-term” OS in nearly a quarter of patients with metastatic gastrointestinal stromal tumors, or GIST, according

University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality

March 27, 2017
The University of Michigan has opened a center designed to provide individualized, structured care for men with a genetic predisposition to prostate cancer. The Prostate…
More News Headlines »
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News

VIDEO: Screening improves detection of curable melanoma

March 24, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement